Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Condition:   Advanced Pancreatic Cancer Intervention:   Biological: Personalized neoantigen tumor vaccine Sponsor:   Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials